NFKB1 and colitis: The antagonistic effects of miR‐23a‐3p inhibitor and angomiR on hAESCs‐mediated colitis recovery suggest the exosomal miR‐23a–TNFR1–NF‐κB axis as the central mechanism responsible for hAESCs therapeutic effects against colitis.